Comparative evaluation of ATB Fungus 2 and Sensititre YeastOne panels for testing in vitro Candida antifungal susceptibility

Revista Iberoamericana de Micologia

Volumn 25, Issue 1, 2008, Pages 3-6

  Eraso, Elena ^a   Ruesga, Maite ^a   Villar Vidal, María ^a   Carrillo Muñoz, Alfonso Javier ^b   Espinel Ingroff, Ana ^c   Quindós, Guillermo ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Associacio Catalana d'Intelligencia Artificial   (Spain)

^c VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ATB Fungus 2; Candida; In vitro antifungal susceptibility; Sensititre YeastOne

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CONTROLLED STUDY; FUNGAL STRAIN; IN VITRO STUDY; INCUBATION TIME; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REPRODUCIBILITY;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; FUNGI; ISSATCHENKIA ORIENTALIS;

EID: 42049118927     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(08)70002-0     Document Type: Article

References (16)

1. Baires-Varguez L, Cruz-García A, Villa-Tanaka L, Sánchez-García S, Gaitán-Cepeda LA, Sánchez-Vargas LO, Quindós G, Hernández-Rodríguez C. Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32C system for identification of clinical isolates of different Candida species. Rev Iberoam Micol 2007; 24: 148-151.
2. Durussel C, Parreno D, Nougier L, Monnin V, Zambardi G, Bille J. Comparative study of various methods, NCCL M27-A2, EUCAST and ATB Fungus 2 (bioMérieux) for the in vitro antifungal susceptibility testing of Candida sp. Clin Microbiol Infect 2004; 10 (Suppl. 3): 112-113.
3. Espinel-Ingroff A. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol 2006; 44: 3616-3622.
4. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Pfaller MA, Rinaldi M, Rodríguez-Tudela JL, Verweij PE. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2005; 43: 3884-3889.
5. Espinel-Ingroff A, Canton E, Gibbs D, Wang A. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole. J Clin Microbiol 2007; 45: 858-864.
6. Espinel-Ingroff A, Pfaller M, Messer SA, Knapp CC, Holliday N, Killian SB. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. J Clin Microbiol 2004; 42: 718-721.
7. Gutiérrez J, Morales P, González MA, Quindós G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 2002; 42: 207-227.
8. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519-1527.
9. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. 2nd Ed. NCCLS document M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
10. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 2007; 20: 133-163.
11. Pfaller MA, Espinel-Ingroff A, Jones RN. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole. J Clin Microbiol 2004; 42: 4577-4580.
12. Quindós G, Ruesga MT, Martín-Mazuelos E, Salesa R, Alonso-Vargas R, Carrillo-Muñoz AJ, Brena S, San MR, Pontón J. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev Iberoam Micol 2004; 21: 63-69.
13. Quindós G, Salesa R, Carrillo-Muñoz AJ, Lipperheide V, Jaudenes L, San-Millan R, Torres-Rodriguez JM, Pontón J. Multicenter evaluation of ATB fungus: a standardized micromethod for yeast susceptibility testing. Chemotherapy 1994; 40: 245-251.
14. Rementeria A, Sánchez-Vargas LO, Villar M, Casals JB, Carrillo-Muñoz AJ, Rodríguez-Andrés C, Eraso E, Quindós G. Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolates. J Chemother 2007; 19: 172-177.
15. Torres-Rodríguez JM, Alvarado-Ramírez E. In vitro susceptibilities to yeasts using the ATB(R) FUNGUS 2 method, compared with Sensititre Yeast One(R) and standard CLSI (NCCLS) M27-A2 methods. J Antimicrob Chemother 2007; 60: 658-661.
16. Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006; 27: 359-366.